Lasa Supergenerics Ltd. News and Updates

Name: Latest research reports of Lasa Supergenerics Ltd. authored by Joindre Capital Services and published by - Trendlyne research reports.
Item: Lasa Supergenerics Ltd.
Rating: 3
Author: Joindre Capital Services

Keep track of all breaking news on Lasa Supergenerics Ltd. from all sources in a single place.

Load latest

Lasa Supergenerics Ltd.

04 Jun 2018

11.15

4.99%

STOCK REVIEW NOTE

Hold: Lasa Supergenerics Ltd.

Recommendation Target

Joindre Capital Services

Lasa Supergenerics is a vertically integrated player spanning the entire veterinary, animal and human healthcare value chainfrom discovery-to-delivery, with established credentials in research, manufacturing and global marketing.Lasa is a veterinary API manufacturing entity For FY18 the company has reported a PAT of Rs 12.32 crs as compared to Rs 2.35 crs last year on a Topline of Rs 249 crs from Rs 220 crs last year. Operating EBIDTA in FY18 totalled Rs 41 crs as compared to Rs 18 crs recorded last year....

Lasa Supergenerics Ltd. is trading above its 100 day SMA of 11.0

Lasa Supergenerics Ltd.

02 May 2018

11.15

4.99%

Lasa Supergenerics Limited

Business Line

Lasa Supergenerics has resumed production at its Mahad (MIDC) unit, following the major fire reported on April 26. The company had then said that the

Lasa Supergenerics Ltd. has lost -53.50% in the last 1 Year

Lasa Supergenerics Ltd.

19 Apr 2018

11.15

4.99%

WHO certificate bodes well for Lasa Supergen

Business Line

Lasa Supergenerics has received WHO-GMP certificate for the unit situated at Mahad, Maharashtra, from the Commissioner of Food and Drug Administration

Lasa Supergenerics Ltd.'s price crossed above 100Day SMA today

Lasa Supergenerics Ltd.

14 Dec 2017

11.15

4.99%

LASA SUPERGENERICS LIMITED

Buy: Lasa Supergenerics Ltd.

Joindre Capital Services

Lasa Supergenerics Limited (Lasa) is a vertically integrated player spanning the entire veterinary, animal and human healthcare value chain from discovery-to-delivery, with established credentials in research, manufacturing and global marketing.Lasa is a veterinary API manufacturing entity, which was acquired in April 2012. for around Rs 6 crs. OSCL acquired Lasa as a part of forward integration for some of its chemicals. From a revenue base of less than 10 crs before acquisition, Lasa has reached revenue of Rs 200 crs now The manufacturing base of Lasa is located at Mahad, in the Konkan region of Maharashtra. It specialises in...

Lasa Supergenerics Ltd. has lost -37.43% in the last 6 Months

Is Lasa Supergenerics Ltd. worth buying?

54 Votes:

Buy 77.78%

Sell 16.67%

Hold 5.56%

64.49% Fall from 52W High

Lasa Supergenerics Ltd. News and Updates

Keep track of all breaking news on Lasa Supergenerics Ltd. from all sources in a single place.